CI confidence interval COI cutoff index ELISA enzyme-linked immunosorbent assay HEV hepatitis E virus IgG immunoglobulin G IgM immunoglobulin M OPA overall percentage agreement PCR polymerase chain reaction WHO World Health Organization 1 Introduction An estimated 900 million people, or ~1/8 of the global population, have been exposed to hepatitis E virus (HEV, Paslahepevirus balayani), and 15–110 million people have recent/ongoing infection [1, 2].
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Mathias Schemmerer
varVAMP: degenerate primer design for tiled full genome sequencing and qPCR - Nature Communications
Abstract Time- and cost-saving surveillance of viral pathogens is achieved by tiled sequencing in which a viral genome is amplified in overlapping PCR amplicons and qPCR. However, designing pan-specific primers for viral pathogens with high genomic variability represents a significant challenge. Here, we present a bioinformatics command-line tool, called varVAMP (variable virus amplicons), which addresses this issue.
Proof of infectivity of hepatitis E virus particles from the ejaculate of chronically infected patients
1 INTRODUCTION The hepatitis E virus (HEV, Paslahepevirus balayani) is a virus with many different aspects, mainly affecting the liver. Acute HEV genotype 1 and 2 (HEV-1 and -2) infections are caused by contaminated water and lead to outbreaks in resource-limited countries.
varVAMP: automated pan-specific primer design for tiled full genome sequencing and qPCR of highly diverse viral pathogens.
Abstract Time- and cost-saving surveillance of viral pathogens is achieved by tiled sequencing in which a viral genome is amplified in overlapping PCR amplicons and qPCR. However, designing pan-specific primers for viral pathogens that have high genomic variability represents a major challenge. Here, we present a bioinformatics command-line tool, called varVAMP (variable virus amplicons).
Hepatitis A outbreak in a refugee shelter in Kiel, northern Germany
1 INTRODUCTION Hepatitis A is a vaccine-preventable infection of the liver caused by the hepatitis A virus (HAV), a picornavirus of the genus Hepatovirus.1, 2 Liver damage is mediated by the immune system.2, 3 The HAV is released from the liver into the blood and bile in small vesicles that protect the virions from neutralizing serum antibodies and promote infection of additional hepatocytes.
Cells | Free Full-Text | Immunomodulation of Natural Killer Cell Function by Ribavirin Involves TYK-2 Activation and Subsequent Increased IFN-γ Secretion in the Context of In Vitro Hepatitis E Virus Infection
Abstract : Hepatitis E virus (HEV) is a major cause of acute hepatitis globally. Chronic and fulminant courses are observed especially in immunocompromised transplant recipients since administration of ribavirin (RBV) does not always lead to a sustained virologic response.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Mathias
Contact Mathias, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack